The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly

• Published in: International clinical psychopharmacology Vol. 7; no. 2; p. 101
• Main Authors: Kerr, J S, Fairweather, D B, Mahendran, R, Hindmarch, I
• Format: Journal Article
• Language: English
• Published: England 01.11.1992
• Subjects: Aged; Aged, 80 and over; Cognition - drug effects; Double-Blind Method; Ethanol - pharmacology; Flicker Fusion - drug effects; Humans; Lorazepam - pharmacology; Male; Memory, Short-Term - drug effects; Middle Aged; Paroxetine - pharmacology; Psychomotor Performance - drug effects; Reaction Time - drug effects; Sleep - drug effects
• ISSN: 0268-1315
• DOI: 10.1097/00004850-199207020-00007

Fifteen healthy male volunteers aged over 60 years received acute and repeated doses of paroxetine 20 mg or placebo, and acute doses of lorazepam 1 mg (as a positive internal control) with or without alcohol (0.6 g/kg of body weight) administered openly in a double blind balanced crossover study in which each subject acted as his own control. Psychomotor performance and cognitive function were assessed using a test battery which included critical flicker fusion, choice reaction time, compensatory tracking, Stroop and memory scanning tests. Subjective ratings of mood and sleep were recorded using line analogue rating scales. The pattern of results indicated that paroxetine had little or no effect on most of the test variables, and in some instances (critical flicker fusion thresholds) improved information processing ability. This was in marked contrast to the lorazepam verum which produced sedation and disruption of performance. Paroxetine had a slight antagonistic effect on alcohol induced sedation whereas impairment of performance with lorazepam was potentiated by co-administration of alcohol. The low behavioural toxicity of paroxetine in elderly volunteers has important implications for the pharmacotherapy of depression.